BioXcel Therapeutics (BTAIQ) Gross Profit (2022 - 2026)
BioXcel Therapeutics (BTAIQ) posted Gross Profit of $160,000 for Q2 2026, compared with $13,000 a year earlier.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Gross Profit (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at BioXcel Therapeutics was $394,000; for FY2025, it was $478,000, up 288.6% from FY2024.
- Annual Gross Profit shows a three-year compound annual growth rate of 10.4% (FY2022 to FY2025).
- In prior years, BioXcel Therapeutics' Gross Profit was $123,000 in FY2024 (+2.5%), $120,000 in FY2023 (-66.2%) and $355,000 in FY2022.
- Quarterly Gross Profit has run from a low of -$956,000 in Q3 2024 to a high of $1.04 million in Q2 2024 over five years.
- According to Business Quant data, Gross Profit for the three prior quarters was -$77,000 (Q1 2026), $224,000 (Q4 2025) and $87,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | BioXcel Therapeutics | 626,099.99 | -93.99 Mn | 160,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160,000.00 |
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | -466,000.00 |
| Sep 30, 2024 | -956,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 502,000.00 |
| Dec 31, 2023 | -338,000.00 |
| Sep 30, 2023 | -171,000.00 |
| Jun 30, 2023 | 431,000.00 |
| Mar 31, 2023 | 197,000.00 |
| Dec 31, 2022 | 229,000.00 |
| Sep 30, 2022 | 126,000.00 |
API Access
BioXcel Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();